Cubist Systematic Strategies, LLC Moderna, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 315,800 shares of MRNA stock, worth $10.8 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

315,800

Previous 298,300 5.87%

Holding current value

$10.8 Million

Previous $35.4 Million 40.42%

% of portfolio

0.13%

Previous 0.25%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $1.36 Million - $2.04 Million	19,541 New	19,541 $1.94 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $1.75 Million - $2.54 Million	-12,880 Reduced 90.47%	1,357 $208,000
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $5.57 Million - $9.88 Million	-47,037 Reduced 76.77%	14,237 $2.56 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $1.24 Million - $2.03 Million	-10,473 Reduced 14.6%	61,274 $7.25 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $3.02 Million - $4.56 Million	25,808 Added 56.18%	71,747 $10.2 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $2.34 Million - $4.34 Million	18,467 Added 67.22%	45,939 $7.91 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $1.77 Million - $2.88 Million	7,820 Added 39.79%	27,472 $6.98 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $329,743 - $719,922	-1,486 Reduced 7.03%	19,652 $7.56 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $1.38 Million - $2.5 Million	-10,645 Reduced 33.49%	21,138 $4.97 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $5.15 Million - $8.78 Million	-47,205 Reduced 59.76%	31,783 $4.16 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $2.47 Million - $6.37 Million	37,499 Added 90.38%	78,988 $8.25 Million
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $1.86 Million - $3.24 Million	34,158 Added 465.94%	41,489 $2.94 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $217,510 - $586,480	7,331 New	7,331 $471,000
Q3 2019 Nov 14, 2019	SELL	$12.26 - $18.07 $1.77 Million - $2.61 Million	-144,610 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.7 - $28.34 $1.98 Million - $4.1 Million	144,610 New	144,610 $2.12 Million

Others Institutions Holding MRNA

# of Institutions

940

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $13.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Moderna, Inc. Transaction History